nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00514	0.00514	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—ACKR2—Crohn's disease	0.00513	0.00513	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—CCR6—Crohn's disease	0.00511	0.00511	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CCR9—Crohn's disease	0.00507	0.00507	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—ACKR2—Crohn's disease	0.00506	0.00506	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00503	0.00503	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—MLN—Crohn's disease	0.00486	0.00486	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—MLN—Crohn's disease	0.0048	0.0048	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—GPR65—Crohn's disease	0.00471	0.00471	CbGpPWpGaD
Enprofylline—ADORA2A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00453	0.00453	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—PTGER4—Crohn's disease	0.0045	0.0045	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00441	0.00441	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CCR9—Crohn's disease	0.00436	0.00436	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—CCR6—Crohn's disease	0.00435	0.00435	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—MLN—Crohn's disease	0.00413	0.00413	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—GPR65—Crohn's disease	0.00405	0.00405	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CCR9—Crohn's disease	0.00396	0.00396	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CCR9—Crohn's disease	0.00396	0.00396	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—ACKR2—Crohn's disease	0.00396	0.00396	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00388	0.00388	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—PTGER4—Crohn's disease	0.00383	0.00383	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—MLN—Crohn's disease	0.00375	0.00375	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CCR9—Crohn's disease	0.00371	0.00371	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—GPR65—Crohn's disease	0.00368	0.00368	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—GPR65—Crohn's disease	0.00368	0.00368	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CCR9—Crohn's disease	0.00366	0.00366	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—RIPK2—Crohn's disease	0.00364	0.00364	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CCR9—Crohn's disease	0.0036	0.0036	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ACKR2—Crohn's disease	0.00356	0.00356	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—GPR65—Crohn's disease	0.00345	0.00345	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—GPR65—Crohn's disease	0.00341	0.00341	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MLN—Crohn's disease	0.00338	0.00338	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CCR9—Crohn's disease	0.00337	0.00337	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CCR6—Crohn's disease	0.00336	0.00336	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—GPR65—Crohn's disease	0.00334	0.00334	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CCR9—Crohn's disease	0.00333	0.00333	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ACKR2—Crohn's disease	0.00323	0.00323	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—GPR65—Crohn's disease	0.00313	0.00313	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—GPR65—Crohn's disease	0.00309	0.00309	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TAGAP—Crohn's disease	0.00309	0.00309	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MLN—Crohn's disease	0.00307	0.00307	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	0.00306	0.00306	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ACKR2—Crohn's disease	0.00303	0.00303	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ACKR2—Crohn's disease	0.00299	0.00299	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—PTGER4—Crohn's disease	0.00295	0.00295	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CCR6—Crohn's disease	0.00289	0.00289	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MLN—Crohn's disease	0.00287	0.00287	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CCR9—Crohn's disease	0.00286	0.00286	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MLN—Crohn's disease	0.00284	0.00284	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TAGAP—Crohn's disease	0.0028	0.0028	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RSPO3—Crohn's disease	0.0027	0.0027	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—GPR65—Crohn's disease	0.00266	0.00266	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TAGAP—Crohn's disease	0.00263	0.00263	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CCR6—Crohn's disease	0.00262	0.00262	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CCR6—Crohn's disease	0.00262	0.00262	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CCR9—Crohn's disease	0.0026	0.0026	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TAGAP—Crohn's disease	0.00259	0.00259	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SEL1L—Crohn's disease	0.00256	0.00256	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00254	0.00254	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CCR6—Crohn's disease	0.00246	0.00246	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RSPO3—Crohn's disease	0.00245	0.00245	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CCR6—Crohn's disease	0.00243	0.00243	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—GPR65—Crohn's disease	0.00242	0.00242	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CCR6—Crohn's disease	0.00238	0.00238	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCR9—Crohn's disease	0.00234	0.00234	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ACKR2—Crohn's disease	0.00234	0.00234	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SEL1L—Crohn's disease	0.00232	0.00232	CbGpPWpGaD
Enprofylline—ADORA1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00231	0.00231	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—PTGER4—Crohn's disease	0.00231	0.00231	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00231	0.00231	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RSPO3—Crohn's disease	0.00229	0.00229	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—Crohn's disease	0.00228	0.00228	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RSPO3—Crohn's disease	0.00227	0.00227	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CCR6—Crohn's disease	0.00223	0.00223	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MLN—Crohn's disease	0.00222	0.00222	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CCR6—Crohn's disease	0.0022	0.0022	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—GPR65—Crohn's disease	0.00218	0.00218	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SEL1L—Crohn's disease	0.00218	0.00218	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	0.00217	0.00217	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—IL3—Crohn's disease	0.00217	0.00217	CbGpPWpGaD
Enprofylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00216	0.00216	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00216	0.00216	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SEL1L—Crohn's disease	0.00215	0.00215	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00214	0.00214	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCR9—Crohn's disease	0.00212	0.00212	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PTGER4—Crohn's disease	0.0021	0.0021	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.0021	0.0021	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TAGAP—Crohn's disease	0.00203	0.00203	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCR9—Crohn's disease	0.00199	0.00199	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—GPR65—Crohn's disease	0.00198	0.00198	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL3—Crohn's disease	0.00197	0.00197	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—IL3—Crohn's disease	0.00197	0.00197	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCR9—Crohn's disease	0.00197	0.00197	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PTGER4—Crohn's disease	0.00196	0.00196	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PTGER4—Crohn's disease	0.00194	0.00194	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.0019	0.0019	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.0019	0.0019	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.0019	0.0019	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—GPR65—Crohn's disease	0.00185	0.00185	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—IL3—Crohn's disease	0.00184	0.00184	CbGpPWpGaD
Enprofylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00184	0.00184	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—GPR65—Crohn's disease	0.00183	0.00183	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—IL3—Crohn's disease	0.00182	0.00182	CbGpPWpGaD
Enprofylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	0.00179	0.00179	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL3—Crohn's disease	0.00179	0.00179	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00178	0.00178	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RSPO3—Crohn's disease	0.00177	0.00177	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00176	0.00176	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—TYK2—Crohn's disease	0.00175	0.00175	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—RASGRP1—Crohn's disease	0.00173	0.00173	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CCR6—Crohn's disease	0.00172	0.00172	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SEL1L—Crohn's disease	0.00168	0.00168	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL3—Crohn's disease	0.00167	0.00167	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—JAK2—Crohn's disease	0.00167	0.00167	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00167	0.00167	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL3—Crohn's disease	0.00165	0.00165	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR ligand binding—CXCL8—Crohn's disease	0.00165	0.00165	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00162	0.00162	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—RASGRP1—Crohn's disease	0.0016	0.0016	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.0016	0.0016	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCR6—Crohn's disease	0.00155	0.00155	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCR9—Crohn's disease	0.00154	0.00154	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.00152	0.00152	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.00152	0.00152	CbGpPWpGaD
Enprofylline—ADORA1—Circadian rythm related genes—IL6—Crohn's disease	0.00147	0.00147	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—GPR65—Crohn's disease	0.00143	0.00143	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—IL3—Crohn's disease	0.00142	0.00142	CbGpPWpGaD
Enprofylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00142	0.00142	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCR6—Crohn's disease	0.00141	0.00141	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RBX1—Crohn's disease	0.0014	0.0014	CbGpPWpGaD
Enprofylline—ADORA1—GPCR ligand binding—CXCL8—Crohn's disease	0.0014	0.0014	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—IL2RA—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PTGER4—Crohn's disease	0.00136	0.00136	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCR6—Crohn's disease	0.00132	0.00132	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCR6—Crohn's disease	0.0013	0.0013	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL3—Crohn's disease	0.00129	0.00129	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00129	0.00129	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—IL2RA—Crohn's disease	0.00128	0.00128	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RBX1—Crohn's disease	0.00127	0.00127	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL2RA—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PTGER4—Crohn's disease	0.00124	0.00124	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.00123	0.00123	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—STAT3—Crohn's disease	0.00123	0.00123	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RBX1—Crohn's disease	0.00119	0.00119	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RIPK2—Crohn's disease	0.00119	0.00119	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RBX1—Crohn's disease	0.00118	0.00118	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL2RA—Crohn's disease	0.00117	0.00117	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL3—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PTGER4—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL2RA—Crohn's disease	0.00116	0.00116	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PTGER4—Crohn's disease	0.00115	0.00115	CbGpPWpGaD
Enprofylline—ADORA2A—Circadian rythm related genes—IL6—Crohn's disease	0.00114	0.00114	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.00112	0.00112	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—UBE2D1—Crohn's disease	0.00112	0.00112	CbGpPWpGaD
Enprofylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.00111	0.00111	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RIPK2—Crohn's disease	0.00108	0.00108	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.00108	0.00108	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL3—Crohn's disease	0.00106	0.00106	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—UBE2D1—Crohn's disease	0.00105	0.00105	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—UBE2D1—Crohn's disease	0.00103	0.00103	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—RASGRP1—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SOCS1—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCR6—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RIPK2—Crohn's disease	0.00101	0.00101	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RIPK2—Crohn's disease	0.001	0.001	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000996	0.000996	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL3—Crohn's disease	0.000988	0.000988	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL3—Crohn's disease	0.000977	0.000977	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000971	0.000971	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—RASGRP1—Crohn's disease	0.000956	0.000956	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—RASGRP1—Crohn's disease	0.000944	0.000944	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000931	0.000931	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000926	0.000926	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—JAK2—Crohn's disease	0.000926	0.000926	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SOCS1—Crohn's disease	0.000925	0.000925	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RBX1—Crohn's disease	0.00092	0.00092	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000905	0.000905	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000896	0.000896	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—TYK2—Crohn's disease	0.000882	0.000882	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000879	0.000879	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—JAK2—Crohn's disease	0.000867	0.000867	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SOCS1—Crohn's disease	0.000866	0.000866	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—IL6—Crohn's disease	0.000858	0.000858	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—JAK2—Crohn's disease	0.000857	0.000857	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SOCS1—Crohn's disease	0.000856	0.000856	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000845	0.000845	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000845	0.000845	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—JAK2—Crohn's disease	0.000841	0.000841	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—TYK2—Crohn's disease	0.000826	0.000826	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—TYK2—Crohn's disease	0.000816	0.000816	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL2RA—Crohn's disease	0.000814	0.000814	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000807	0.000807	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—SMAD3—Crohn's disease	0.000798	0.000798	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000792	0.000792	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—JAK2—Crohn's disease	0.000788	0.000788	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000782	0.000782	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000782	0.000782	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—JAK2—Crohn's disease	0.000778	0.000778	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CXCL8—Crohn's disease	0.000768	0.000768	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL3—Crohn's disease	0.000763	0.000763	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—SMAD3—Crohn's disease	0.000748	0.000748	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL2RA—Crohn's disease	0.000739	0.000739	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—SMAD3—Crohn's disease	0.000739	0.000739	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000738	0.000738	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CXCL8—Crohn's disease	0.000719	0.000719	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CXCL8—Crohn's disease	0.00071	0.00071	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL2RA—Crohn's disease	0.000692	0.000692	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL2RA—Crohn's disease	0.000684	0.000684	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.00067	0.00067	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000669	0.000669	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—TYK2—Crohn's disease	0.000637	0.000637	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000611	0.000611	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—JAK2—Crohn's disease	0.000608	0.000608	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—SMAD3—Crohn's disease	0.000577	0.000577	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TYK2—Crohn's disease	0.000574	0.000574	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000555	0.000555	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—JAK2—Crohn's disease	0.000547	0.000547	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL2RA—Crohn's disease	0.000535	0.000535	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TYK2—Crohn's disease	0.000521	0.000521	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CXCL8—Crohn's disease	0.000499	0.000499	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—JAK2—Crohn's disease	0.000497	0.000497	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TYK2—Crohn's disease	0.000488	0.000488	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TYK2—Crohn's disease	0.000482	0.000482	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL6—Crohn's disease	0.000475	0.000475	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—JAK2—Crohn's disease	0.000465	0.000465	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—JAK2—Crohn's disease	0.00046	0.00046	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CXCL8—Crohn's disease	0.000454	0.000454	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL6—Crohn's disease	0.000431	0.000431	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CXCL8—Crohn's disease	0.000425	0.000425	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CXCL8—Crohn's disease	0.00042	0.00042	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL6—Crohn's disease	0.000404	0.000404	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—STAT3—Crohn's disease	0.000402	0.000402	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL6—Crohn's disease	0.000399	0.000399	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TYK2—Crohn's disease	0.000377	0.000377	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—STAT3—Crohn's disease	0.000365	0.000365	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—JAK2—Crohn's disease	0.000359	0.000359	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—STAT3—Crohn's disease	0.000342	0.000342	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—STAT3—Crohn's disease	0.000337	0.000337	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CXCL8—Crohn's disease	0.000328	0.000328	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL6—Crohn's disease	0.000312	0.000312	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL6—Crohn's disease	0.000281	0.000281	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—STAT3—Crohn's disease	0.000264	0.000264	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL6—Crohn's disease	0.000255	0.000255	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL6—Crohn's disease	0.000239	0.000239	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL6—Crohn's disease	0.000236	0.000236	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL6—Crohn's disease	0.000184	0.000184	CbGpPWpGaD
